Featured ITCR Tools

The Cancer Proteome Atlas

TCPA is an integrated bioinformatics resource dedicated to Reverse Phase Protein Array (RPPA)-based functional proteomic data. TCPA-patient contains ~8,000 patient samples; TCPA-cell line contains 1,500 cell line samples; and TCPA-perturbation contains perturbed protein expression profiles in >12,000 cell line samples in response to ~170 drug compounds.

Learn More

Featured ITCR Tools

QIIME 2

QIIME 2 is a microbiome bioinformatics platform that is widely used for investigation of the human microbiome including studies investigating how our microbiota may impact carcinogenesis or the efficacy of cancer treatment, how cancer treatment may impact the microbiota, and associations between the microbiome and cancer prognosis.

Learn More

Featured ITCR Tools

CIViC

CIViC is an open access, open source, community-driven web resource for Clinical Interpretation of Variants in Cancer.

Learn More

JCO Clinical Cancer Informatics

This special issue of JCO Clinical Cancer Informatics,
“Informatics Tools for Cancer Research and Care – Bridging
the Gap Between Innovation and Implementation,” features
30 open access articles describing select ITCR tools.

Read it now

Congratulations, ITCR Poster Winners!

The votes have been counted! Join us in celebrating the
poster winners from the ITCR annual meeting and check
out the awesome tools they have developed.

Learn More

Funding Opportunities


ITCR has issued four Funding Opportunity Announcements aimed at successive stages of informatics technology development.


RFA-CA-22-024 (U24 Sustainment): Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)


RFA-CA-22-023 (U24 Advanced Development): Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)


RFA-CA-22-022 (U01): Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)


RFA-CA-22-021 (R21): Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)